Table 4.
Multivariate analysis in primary and secondary prevention.
| Level | OR (IC 2.5–97.5%) | P value |
|---|---|---|
| Primary prevention | ||
| High intensity LLT | 1.008 (0.98–1.03) | 0.50 |
| LDL-C reduction by at least 50% | 1.082 (1.05–1.11) | 0.00001 |
| LDL-C < 3.36 mmol/L | 1.07 (1.04–1.1) | 0.00001 |
| LDL-C < 2.58 mmol/L | 1.029 (1.01–10.4) | 0.0003 |
| LDL-C < 1.81 mmol/L | 1.003 (1–1.006) | 0.05 |
| Secondary prevention | ||
| High intensity LLT | 1.09 (1.04–1.15) | 0.0005 |
| LDL-C reduction by at least 50% | 1.17 (1.11–1.23) | 0.00001 |
| LDL-C < 3,36 mmol/L | 1.17 (1.11–1.23) | 0.00001 |
| LDL-C < 2.58 mmol/L | 1.10 (1.05–1.16) | 0.0002 |
| LDL-C < 1.81 mmol/L | 1.007 (0.99–1.02) | 0.36 |
Primary prevention adjusted by age, high blood pressure, smoking and body mass index. Secondary prevention adjusted by age, high blood pressure, smoking.
LDL-c low-density lipoprotein cholesterol, LLT Lipid lowering therapy.